• Join
  • Login
  • Contact

Search abstracts

Controlled distribution system of belimumab in a teaching hospital: a 2 years retrospective analysis

  • At: 2016 FIP Congress in Buenos Aires (Argentina)
  • Type: Poster
  • By: BIDON, Doriane (Pitié-Salpêtrière hospital, Pharmacy, PARIS, France)
  • Co-author(s): Doriane BIDON:Pharmacy,Pitié-Salpêtrière hospital,PARIS,France|Carole METZ:Pharmacy,Pitié-Salpêtrière hospital,PARIS,France|Neila BENAMEUR:Pharmacy,Pitié-Salpêtrière hospital,PARIS,France|Helga JUNOT:Pharmacy,Pitié-Salpêtrière hospital,PARIS,France|Marie-Hélène FIEVET:Pharmacy,Pitié-Salpêtrière hospital,PARIS,France|Zahir AMOURA:internal medicine,Pitié-Salpêtrière hospital,PARIS,France|Patrick TILLEUL:Pharmacy,Pitié-Salpêtrière hospital,PARIS,France
  • Abstract:

    Since 2012, belimumab (BLM) is licensed for still highly active systemic lupus erythematosus (SLE) in spite of standard of care therapy BLM is administered in day hospital setting with prior pharmaceutical control. 

    Patient data treated with BLM were collected by the pharmacy including: age, sex ratio, number of regimens before BLM, adverse


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses